HLS Therapeutics (HLTRF) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free HLTRF Stock Alerts $3.56 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest HLS Therapeutics Short Interest DataCurrent Short Volume2,000 sharesPrevious Short Volume2,200 sharesChange Vs. Previous Month-9.09%Dollar Volume Sold Short$6,221.80Short Interest Ratio / Days to Cover20.0Last Record DateMarch 31, 2024Today's Trading Volume0 sharesAverage Trading Volume1,064 sharesToday's Volume Vs. Average0% Short Selling HLS Therapeutics ? Sign up to receive the latest short interest report for HLS Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHLTRF Short Interest Over TimeHLTRF Days to Cover Over TimeHLTRF Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 HLS Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,000 shares $6,221.80 -9.1%N/A20 $3.11 3/15/20242,200 shares $6,843.98 -26.7%N/A7.3 $3.11 2/29/20243,000 shares $9,570.00 No ChangeN/A0 $3.19 2/15/20243,000 shares $9,570.00 -11.8%N/A30 $3.19 1/15/20242,500 shares $9,600.00 +13.6%N/A0 $3.84 12/31/20232,200 shares $8,448.00 -35.3%N/A3.1 $3.84 Get the Latest News and Ratings for HLTRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20233,400 shares $9,327.22 No ChangeN/A1.5 $2.74 11/30/20233,400 shares $9,327.22 +17.2%N/A1.9 $2.74 11/15/20232,900 shares $8,526.00 No ChangeN/A9.7 $2.94 10/31/20232,900 shares $10,875.00 No ChangeN/A0.7 $3.75 10/15/20232,900 shares $11,136.00 No ChangeN/A0.7 $3.84 9/30/20232,900 shares $11,136.00 No ChangeN/A0.7 $3.84 9/15/20232,900 shares $9,570.00 +383.3%N/A0.6 $3.30 8/31/2023600 shares $1,980.00 -14.3%N/A0.1 $3.30 8/15/2023700 shares $3,185.00 -56.3%N/A0.1 $4.55 7/31/20231,600 shares $7,600.00 No ChangeN/A0.3 $4.75 7/15/20231,600 shares $7,440.00 -5.9%N/A0.3 $4.65 6/30/20231,700 shares $8,075.00 -54.1%N/A2.8 $4.75 6/15/20233,700 shares $17,593.50 +48.0%N/A0.2 $4.76 5/31/20232,500 shares $8,225.00 -69.1%N/A0.3 $3.29 5/15/20238,100 shares $27,702.00 -21.4%N/A3.9 $3.42 4/30/202310,300 shares $44,908.00 No ChangeN/A0.4 $4.36 4/15/202310,300 shares $47,954.05 +33.8%N/A2.4 $4.66 3/31/20237,700 shares $34,419.00 +4.1%N/A0.4 $4.47 3/15/20237,400 shares $46,694.00 No ChangeN/A74 $6.31 2/28/20237,400 shares $46,990.00 No ChangeN/A74 $6.35 2/15/20237,400 shares $48,468.52 No ChangeN/A24.7 $6.55 1/31/20237,400 shares $52,910.00 -39.3%N/A6.2 $7.15 1/15/202312,200 shares $88,450.00 -39.3%N/A0 $7.25 12/30/202220,100 shares $145,725.00 -9.1%N/A10.6 $7.25 12/15/202222,100 shares $168,844.00 -87.8%N/A1.2 $7.64 11/30/2022181,500 shares $1.26 million +53.9%N/A14.1 $6.92 11/15/2022117,900 shares $821,763.00 +77.3%N/A12.7 $6.97 10/31/202266,500 shares $472,150.00 +191.7%N/A23.8 $7.10 10/15/202222,800 shares $145,692.00 +6.1%N/A1.3 $6.39 9/30/202221,500 shares $143,190.00 +141.6%N/A1 $6.66 9/15/20228,900 shares $71,823.00 +3.5%N/A22.3 $8.07 8/31/20228,600 shares $86,000.00 +8.9%N/A86 $10.00 8/15/20227,900 shares $80,185.00 -4.8%N/A19.8 $10.15 7/31/20228,300 shares $83,664.00 +3.8%N/A5.2 $10.08Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 HLTRF Short Interest - Frequently Asked Questions What is HLS Therapeutics' current short interest? Short interest is the volume of HLS Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 2,000 shares of HLTRF short. Learn More on HLS Therapeutics' current short interest. What is a good short interest ratio for HLS Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HLTRF shares currently have a short interest ratio of 20.0. Learn More on HLS Therapeutics's short interest ratio. Is HLS Therapeutics' short interest increasing or decreasing? HLS Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,000 shares, a decrease of 9.1% from the previous total of 2,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short HLS Therapeutics stock? Short selling HLTRF is an investing strategy that aims to generate trading profit from HLS Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HLS Therapeutics? A short squeeze for HLS Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HLTRF, which in turn drives the price of the stock up even further. How often is HLS Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HLTRF, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRDF Short Squeeze ACRHF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HLTRF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace